Impact of anakinra use on clinical outcomes in children with moderate or severe multisystem inflammatory syndrome in children: a propensity score matched retrospective cohort study
Abstract Background The treatment of children with multisystem inflammatory syndrome in children (MIS-C) related to SARS-CoV-2 infection involves immunomodulatory therapies such as IVIG and steroids. Anakinra, an interleukin-1 receptor inhibitor, has also been used, but its effectiveness is not esta...
Saved in:
Main Authors: | Esra B. Akkoyun (Author), Zachary Most (Author), Harita Katragadda (Author), Andrew Yu (Author), Lorien Nassi (Author), Nicole Oakman (Author), Sarah Ginsburg (Author), Mia Maamari (Author) |
---|---|
Format: | Book |
Published: |
BMC,
2023-11-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Anakinra treatment in multisystemic inflammatory syndrome in children (MIS-C) associated with COVID-19
by: Şengül Çaǧlayan, et al.
Published: (2022) -
The Effect of Biologics in the Treatment of Multisystem Inflammatory Syndrome in Children (Mis-C): A Single-Center Propensity-Score-Matched Study
by: Ozge Basaran, et al.
Published: (2023) -
Clinical outcomes and safety of anakinra in the treatment of multisystem inflammatory syndrome in children: a single center observational study
by: Brian L.P. Dizon, et al.
Published: (2023) -
Case Report: Use of Anakinra in Multisystem Inflammatory Syndrome During COVID-19 Pandemic
by: Sara Della Paolera, et al.
Published: (2021) -
The Efficacy of Acupuncture on Tic Disorders in Children: A Retrospective and Propensity Score-Matched Study
by: Hai-Zhen You, et al.
Published: (2021)